Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

NCT00694304 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
535
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

H. Lundbeck A/S